IN Pipeline 20181103


 

KKR

** Gene sequencing company Illumina Inc said on Thursday it plans to buy smaller rival Pacific Biosciences of California Inc in an all-cash deal valued at $1.2 billion, expanding its capabilities as the market grows.

** Australia’s MYOB Group said it will grant due diligence to KKR & Co after the U.S. buyout giant sweetened its offer to take full control of the accounting software provider firm to A$1.8 billion ($1.3 billion).

** Canada’s Encana Corp will buy Newfield Exploration Co for $5.5 billion, giving the natural gas producer greater access to North America’s biggest oilfields, and potentially spurring further deals.

** U.S. drugmaker Pfizer Inc is considering options, including a sale of its women’s health portfolio, Bloomberg reported, citing sources familiar with the matter.

** Canadian pipeline operator TransCanada Corp said it is eyeing joint ventures and asset sales, among other options, to finance the construction of its $8 billion Keystone XL crude oil pipeline.

DISCLAIMER: This is a beta blog.  The information is provided by AP, Bloomberg, Forbes, Fortune, preqin, Reuters, TechCrunch, VentureBeat, Wall Street Journal (WSJ), and other 3rd party sources. Please check with the company website or venture capital firm for a press release as this is a beta blog that does not update information.

mergers

 

Author: JD Morris

Learn more about JD Biography on LinkedIn: http://www.linkedin.com/in/jdmorris

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s